The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law FDA Peptide Reclassification 2026: What It Means for Providers New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn Sermorelin: Understanding How It Works, Its Uses, and What People Need to Know Nirvanix Health Blog